Russia

Medisorb

Investment

2017

Turnover (2017)

€ nan. m

Personnel (2017)

490

Funds’ ownership (diluted)

-

Website

Medisorb Group is one of the leading traditional generic drug producers in Russia with the full cycle of pharmaceutical production that is aligned with GMP standards. Current portfolio of products consists of 22 drugs (34 SKUs) presented by traditional generics and own unique products.

Case team